Advertisement

Related Videos

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Advertisement

Advertisement




Jun
12
Today In Oncology
Can AI Provide an Early Alert for Breast Cancer Before Diagnosis
Urologic Surgeon Sworn in as AMA President
Head and Neck Cancer HPV-DeepSeek May Identify Earlier Signs of Postoperative Recurrence
FDA Approves Atezolizumab for Adjuvant Treatment of MRD-Positive MIBC
Perioperative Serplulimab in PD-L1–Positive Gastric Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo